# US 2022/0007975 A1 · Portable Device and Method for Non-Invasive Blood Glucose Level Estimation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0007975 A1
- Document ID: US20220007975A1
- Status: Published application
- Kind: A1
- Application number: 17/424,734
- Filed: 2020-01-17
- Published: 2022-01-13
- Earliest claimed: 2019-01-22
- Assignees: Universidad de Sevilla
- Applicants: Universidad De Sevilla
- Inventors: Luis Javier REINA TOSINA; Laura Mª ROA ROMERO; David NARANJO HERNÁNDEZ
- Web page: https://patentgrep.com/patent/US20220007975A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- G01N 21/3151: {using two sources of radiation of different wavelengths (G01N21/33 - G01N21/39 take precedence)}
- A61B 5/0002: {Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network (endoradiosondes A61B5/07)}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B 5/6826: {Finger}
- A61B 5/7207: {of noise induced by motion artifacts}
- A61B 5/7225: {Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation (input circuits for detecting, measuring, or recording bioelectric or biomagnetic signals A61B5/30; specific diagnostic methods using bioelectric or biomagnetic signals A61B5/316)}
- A61B 5/725: {using specific filters therefor, e.g. Kalman or adaptive filters (specific diagnostics methods using using bioelectric or biomagnetic signals A61B5/316)}
- A61B 5/7264: {Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems}
- A61B 5/746: {Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms}
- G01N 21/359: using near infrared light
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/02438: {with portable devices, e.g. worn by the patient}
- A61B 5/0531: Measuring skin impedance
- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- A61B 5/1117: {Fall detection}
- A61B 5/14551: {for measuring blood gases}
- A61B 5/318: Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B 5/4869: {Determining body composition}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- G01N 2201/0221: Portable; cableless; compact; hand-held
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The invention relates to a device (1) comprising a measuring unit (2) with a measuring module (4) for measuring the glucose level, a first computer module (5) for processing data from a first part of the process for measuring the glucose level, a first communications module (6), a first data storage module (7) and a pushbutton (8). The device also comprises a personal monitoring unit (3) with second and third communication modules (17, 20), a second computer module (18) for processing data from a second part of the process for measuring the glucose level, an interface module (19) and a second data storage module (22). Also described is a method for non-invasive blood glucose level estimation.

## Claims

### Claim 1

A device (1) for non-invasive blood glucose level estimation, comprising:
a measuring unit (2), comprising the following modules:
a measuring module (4) for measuring the glucose level, comprising a plurality of elements configured to perform a process for non-invasive blood glucose level measurement;
a first computer module (5), configured to control the measuring module (4), and to process data on a first part of the process for measuring blood glucose level, starting from the data provided by the measuring module (4);
a first communications module (6), configured to receive configuration commands and send the data associated with such commands to the first computer module (5);
a first data storage module (7), configured to store the information from the measuring unit (2);
a pushbutton (8), configured for activating the measuring unit (2);
a personal monitoring unit (3), comprising:
a second communications module (17) intended to establish bidirectional wireless communications with at least the measuring unit (2);
a second computer module (18), configured to process data on a second part of the process for measuring the blood glucose level;
an interface module (19), configured to display the information from the measuring unit (2) and the data provided by the second computer module (18), and to enable the user to interact;
a third communications module (20), configured to establish bidirectional wireless communications with an external service provider (21);
a second data storage module (22), configured to store data from the personal monitoring unit (3);
and characterised in that the measuring module (4) comprises:
a first light emitter E1 (9), activatable from the first computer module (5), and configured to emit with a wavelength corresponding to a maximum absorbance in the absorption spectrum of the glucose molecule within the near-infrared range, which strikes on the skin of a body area (10) irrigated by a vascular bed;
a second E2 light emitter (11), activatable from the first computer module (5), and configured to emit with a wavelength corresponding to a minimum absorbance in the absorption spectrum of the glucose molecule, and arranged close to the light emitter E1 (9);
a photodetector (12), sensitive to the wavelength of the first and second light E1 and E2 (9, 11), configured to generate an electrical current signal (S1), the amplitude of which depends on the intensity of light received in the sensitivity spectrum of the photodetector (12);
a first amplification step (13), which generates an electrical voltage signal (S2), amplified from the electrical current signal (S1), when said electrical current signal (S1) is weak;
a first filtering step (14) which abstracts the components of the electrical voltage signal (S2) which vary due to the arterial flow, generating a third signal (S3);
a second amplification step (15), which generates an amplified signal (S4) from the third signal (S3);
a second filtering step (16), which abstracts the components of the electrical voltage signal (S2) related to stationary properties in the measurement, as well as possible motion artefacts and other sources of low-frequency error, generating a fifth signal (S5).

### Claim 2 (depends on 1)

The device according to claim 1, characterised in that the first and second light emitters E1 and E2 (9, 11) are arranged such that the light beams cross through a relatively translucent body area (10), such as a finger or an ear lobe, and are captured by the photodetector (12) located on the opposite side of said body area (10).

### Claim 3 (depends on 1)

The device according to claim 1, characterised in that it is covered by a casing opaque to the light spectrum wherein the photodetector (12) is sensitive.

### Claim 4 (depends on 3)

The device according to claim 3, characterised in that the opaque casing is configured to exert a constant pressure on the body area (10).

### Claim 5 (depends on 1)

The device according to claim 1, characterised in that the measuring unit (2) and the personal monitoring unit (3) comprise a real-time timing system configured to manage instants of measurement and periods of time of the operations.

### Claim 6 (depends on 1)

The device according to claim 1, characterised in that the measuring unit (2) comprises a temperature module (24) configured to measure the temperature in the body area (10) wherein the measurement is performed.

### Claim 7 (depends on 1)

The device according to claim 1, characterised in that the personal monitoring unit (3) is configured to additionally measure physiological variables selected from: respiratory rate, heart rate, ECG, heart rate variability, body temperature, physical activity, falls, body composition, skin impedance and pulse oximetry.

### Claim 8 (depends on 1)

The device according to claim 1, characterised in that the measuring unit (2) and the personal monitoring unit (3) are physically separated or integrated in a monolithic device (23).

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A method for non-invasive blood glucose level estimation using the device described in any one of claims 1 to 8, performed in a distributed manner by the first computer module (5) and the second computer module (18), and comprising the following operations:
performing a first estimation (28) of a first parameter (D1) as the average value of the fifth signal (S5) during a pre-configured time period P1 (25) wherein the light emitters E1 (9) and E2 (11) are deactivated;
performing a second estimation (29) of a second parameter (D2) as the average value of the fifth signal (S5) during a second pre-configured time period P2 (26) wherein the emitter E1 (9) is activated, and the emitter E2 (11) is deactivated;
performing a third estimation (30) of a third parameter (D3) during that second pre-configured time period P2 (26), wherein the third parameter corresponds to the average value of the differences between successive maxima and minima identified in the pulsating signal (S4);
performing a fourth estimation (31) of a fourth parameter (D4) as the average value of the fifth signal (S5) during a third pre-configured time period P3 (27) wherein the emitter E2 (11) is activated, and the emitter E1 (9) is deactivated;
performing a fifth estimation (32) of a fifth parameter (D5) during the third pre-configured time period P3 (27), wherein such fifth parameter (D5) corresponds to the average value of the differences between successive maxima and minima identified in the pulsating signal (S4);
estimating the blood glucose level (33) starting from a model which depends on the parameters from the first to the fifth (D1, D2, D3, D4, D5) wherein the model isolates the influence of glucose by weighting the dependence with respect to these parameters (D1, D2, D3, D4, D5) according to two conditions: with the glucose molecules subjected to a light associated with a maximum absorbance in the second parameter (D2) and third parameter (D3) or subjected to a light associated with a minimum absorbance in the fourth parameter (D4) and the fifth parameter (D5) and wherein the influence of the ambient light in the measurement of the photodetector (12) is weighted in the dependence with respect to the first parameter (D1), and wherein the influence of the signal components related to stationary properties in the measurement, with motion artefacts and error sources generated by low-frequency signals, is weighted in the dependence with respect to the second and fourth parameters (D2, D4) and the model isolates the influence of the arterial blood in the estimation, and eliminates the influence of other tissues, weighting the dependence with respect to the third and fifth parameters (D3, D5).

### Claim 10 (depends on 8)

The method of claim 8 wherein the dependence of the model for glucose level estimation with respect to the first to fifth parameters (D1, D2, D3, D4, D5) is performed based on coefficients which can be configured remotely by means of sending commands, and wherein the values of the coefficients generate a generalised model for use in different users, or a customised model for an individual use, or a generalised and customisable model including the dependency with other parameters related to the particular characteristics of the user.

### Claim 11 (depends on 8)

The method of claim 8 incorporating the measurement of the temperature module (24) as a parameter of the model for glucose level estimation.

### Claim 12 (depends on 8)

The method of claim 8 incorporating an operation which activates an alarm locally and remotely when the glucose estimation records a value considered unsuitable.
